ArticleFrontiers in bioengineering and biotechnology2021

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein.

Johannes Ruhnau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.